ANXA6 is down-regulated in many cancers, and acts as cancer suppressor, which include highly aggressive triple-negative breast cancer (TNBC) subtypes [21, 22], gastric cancer [23], cervical cancer [24], and hepatocellular carcinoma [25], bladder cancer [26]. Here, ANXA6 is linked to urinary bladder carcinoma.